Barroso-García, N.; Martín-Varillas, J.L.; Ferraz-Amaro, I.; Sánchez-Bilbao, L.; Martín-Gutiérrez, A.; Adán, A.; Hernanz-Rodríguez, I.; Beltrán-Catalán, E.; Cordero-Coma, M.; Díaz-Valle, D.;
et al. Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’s Disease. J. Clin. Med. 2024, 13, 7388.
https://doi.org/10.3390/jcm13237388
AMA Style
Barroso-García N, Martín-Varillas JL, Ferraz-Amaro I, Sánchez-Bilbao L, Martín-Gutiérrez A, Adán A, Hernanz-Rodríguez I, Beltrán-Catalán E, Cordero-Coma M, Díaz-Valle D,
et al. Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’s Disease. Journal of Clinical Medicine. 2024; 13(23):7388.
https://doi.org/10.3390/jcm13237388
Chicago/Turabian Style
Barroso-García, Nuria, José Luis Martín-Varillas, Iván Ferraz-Amaro, Lara Sánchez-Bilbao, Adrián Martín-Gutiérrez, Alfredo Adán, Inés Hernanz-Rodríguez, Emma Beltrán-Catalán, Miguel Cordero-Coma, David Díaz-Valle,
and et al. 2024. "Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’s Disease" Journal of Clinical Medicine 13, no. 23: 7388.
https://doi.org/10.3390/jcm13237388
APA Style
Barroso-García, N., Martín-Varillas, J. L., Ferraz-Amaro, I., Sánchez-Bilbao, L., Martín-Gutiérrez, A., Adán, A., Hernanz-Rodríguez, I., Beltrán-Catalán, E., Cordero-Coma, M., Díaz-Valle, D., Hernández-Garfella, M., Martínez-Costa, L., Díaz-Llopis, M., Herreras, J. M., Maíz-Alonso, O., Torre-Salaberri, I., Atanes-Sandoval, A., Insúa, S., Almodóvar-González, R.,
... Blanco, R.
(2024). Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’s Disease. Journal of Clinical Medicine, 13(23), 7388.
https://doi.org/10.3390/jcm13237388
